Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06545630
PHASE1
Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases
Sponsor: West China Hospital
View on ClinicalTrials.gov
Summary
The aim of this study is to explore the safety and efficacy of tumor antigen-sensitized DC vaccine in postoperative adjuvant treatment of R0 excision Colorectal Cancer Liver Metastases.
Official title: Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for R0 Resection of Colorectal Cancer Liver Metastases
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2023-11-01
Completion Date
2026-05
Last Updated
2024-08-09
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Tumor antigen-sensitized DC vaccine
subcutaneous administration
Locations (1)
Colorectal Cancer Center, West China Hospital
Chengdu, Chengdu/Sichuan, China